Loading...
Historically, patients with significant left-main coronary artery disease (CAD) have been managed with coronary-artery bypass grafting (CABG), based on findings of substantially better survival with CABG compared to medical therapy. Recent improvements in drug-eluting stents (DES), adjunct pharmacology, and intravascular imaging have renewed clinicians' interest in using percutaneous coronary intervention (PCI) for these patients, but several randomized trials suggesting similar death rates involved only 5-year follow-up. To evaluate longer-term outcomes, investigators performed an extended follow-up (≥10 years; NCT03871127) of 600 patients with significant left-main CAD who had been randomized to PCI with first-generation sirolimus-eluting…